Mass.-based Moderna slashing workforce amid declining COVID vaccine sales

Massachusetts-based Moderna announced Thursday that it plans to slash the size of its global workforce by about 10% in the coming months as COVID vaccine sales continue to decline.

In a memo that was shared companywide, Moderna CEO Stephane Bancel said the company expects “to be fewer than 5,000 colleagues strong” by the end of 2025.

“This decision was not made lightly. It impacts teammates and friends who have dedicated themselves to our mission and who have helped build Moderna,” Bancel wrote. “I want to express, on behalf of the entire Executive Committee and on behalf of patients you have served, our deepest thanks for everything you have contributed.”…

Story continues

TRENDING NOW

LATEST LOCAL NEWS